TCTAP 2019 Webcast
's Information
| Name | Duk-Woo Park |
| Country | Korea (South) |
| Job | Interventional Cardiologist |
Other summitMD.com content(s) by This
Cases
- Stent Fracture with total occlusion after Drug-Eluting Stent Implantation
- Exercise-induced ST-segment elevation during treadmill exercise testing
- FFR versus Angiography for ISR lesion
- FFR versus Angiography for ulcerated lesion
- Undetected significant distal LM disease in coronary CT
- Left Main bifurcation treatment with kissing stenting technique
- Left Main ostial treatment with simple stenting
- Distal LMCA stenosis Treated by Simple Cross-Over Stenting
- Heavily Calcified Long RCA Lesion Treated Using Rotational Atherectomy
- LM Bifurcation Lesion Treated by TAP Technique and Drug Eluting Balloon
- Rotablation and Stent Insertion for Left Anterior Descending Artery Stenosis with Severe Calcification
- LAD Bifurcation Treated by Balloon Crush Technique
- Hybrid PCI Using BVS and DES
- Transcatheter Aortic Valve Implantation with the Edwards SAPIEN 3
- Transcatheter Aortic Valve Implantation with the Edwards SAPIEN 3
- LM Bifurcation Stenting with Crush Technique
- BVS Stenting at Diffuse Long Lesion
- The QCA Guided BVS Stenting
- Transcatheter Aortic Valve Replacement
- Balloon-expandable Transcatheter Aortic Valve Prosthesis(Edwards SAPIEN 3) in Severe Aortic Stenosis with Large Size Bicuspid Aortic Valve
- Overlapped Stenting and Kissing Balloon of LM Bifurcation Lesion
- Valve-in-Valve Transcatheter Aortic Valve Implantation With The Edwards SAPIEN 3
- Transcatheter Aortic Valve Replacement With Evolut R in a Patient with Severe Degenerative Aortic Regurgitation
- Crush Technique for the LM Bifurcation Lesion
Slide Presentations
- Impact of DES on Diabetes Mellitus in Long Coronary Lesion
- Meta-Analysis of 3,900 Patients with Left Main Disease Intervention (BMS vs DES vs CABG)
- VH AMC Clinical Experience
- Wrapping Up Current Clinical Trials and Future Study Program
- Use of VH-Findings as Surrogate Marker for Anti-Atherosclerotic Drug
- DES vs. CABG for Multivessel Disease: Same or Different Interpretation from Registry to RCT
- Seeing Is Believing. IVUS Is A Mandatory in All Patients!
- Alternative and Next Antiplatelet Therapy Beyond ADP Blocker
- Early DES - What Did We Learn - Updates from the ZEST Trial
- AMC Experience of the Intervention for the Structural Heart Disease
- Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN–MAIN (ASAN Medical Center–Left MAIN Revascularization) Registry
- Use of a Point-of-Care Platelet Function Assay to Improve the Prediction of Atherothrombotic Events after DES Implantation: ASAN-VerifyNow Registry
- Where to Go? - Comparative Analysis: BMS, DES vs. BVS / - The Next Step: BVS in Challenging Lesions
- Can Different DES Make a Different Outcome?
- RDN; Indications & Evidence and Future
- Shifting the Paradigm for Lipid Management: Pathways in Achieving Improved ASCVD Outcomes
- Can BVS Replace the Metal Stent?: Current Status and Future Perspective
- Comparative Outcomes of New-Generation DES: IRIS-DES
- BVS: They Will Replace Metallic DES?
- Effect of Statin Therapy on Cardiovascular Outcome in Dyslipidemic Patients with CKD
- DES Thrombosis and Restenosis: Still Problematic in Current Real-World with Updated DES
- BRS in Left Main PCI: Clinical Data and Experience
- Bifurcation PCI Summary; Technique or Concept?
- How Much Promising BRS in Real-Practice PCI?; Updated Real-World Experience and Registry Data
- Growing Importance of Evidence in the Management of High CV Risk Patients
- SYNERGY : Latest Experience from Korea
- Future in Transcatheter Heart Valve Treatment
- Bifurcation PCI 2019: What Are Novel Changes for Technique or Concept?
- Generalizability of EXCEL and NOBLE; Comparison with IRIS-MAIN Registry
- Contemporary Bifurcation PCI; How Advance over Time?
- Long-Term Durability Issue of TAVR; Uncertainty or Would Be OK
- Permanent Pacemaker and Para-valvular Leakage: How to Avoid?
- How Do I Choose Sapien 3, Evolut R or Lotus in My Practice?
- [Taped Case] TAVR with Sapien
- Mainstream of TAVR: Minimalist Approach
- Trends and Outcomes of Non-LM and LM Bifurcation PCI
- All Contemporary DES Comparison; Data from Real-World Registry (IRIS-DES)
- Optimal Antithrombotic Therapy and Ongoing Clinical Trials
- CTEPH; Diagnosis & Treatment
- Standard vs. Minimalist TAVR: When and How to Change?
- TAVR - Moving to Lower Risk: STS or Age Per Se?
- Keynote Lecture on Bifurcation PCI: Expert\'s Concept and Technique
- Heavily Calcified Lesion: Rotational Atherectomy and Others
- Top 10 Tips on Bifurcation PCI
- Highlighting 20 years of CV Protection with Lipitor
- OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients
- Valve Thrombosis, Durability and Ongoing Antithrombotic Trials for TAVR
- EBC-MAIN Like Analysis Using the Largest Real-World Left Main Database
- Comparative Outcomes of Contemporary DES in Real-World: Is There Difference?
- Clinical Impact of Periprocedural Myocardial Injury After TAVR
- TAVR in Asia: Current Challenges and Future Direction
- Metallic DES Are All Equivalent!
- Ture Distal Left Main PCI (Medina 1,1,1 or 1,0,1) Contemporary Strategy: Provisional vs. Complex
- Time to Consider Different P2Y12 Strategy for Complex PCI/CHIP Patients: From OPTIMA to TAILORED-PCI Trial
- Minimalist TAVR with Edwards SAPIEN 3 Valve
- Integrated Use of FFR and IVUS in Non-LM Bifurcation PCI
- Severe Coronary Calcification: Predictors, Managing Strategy, and Outcomes
- PCI in Post-TAVR Patients: Beyond the Barrier
- How To Do Successful Registry Studies?
- East-Asian Paradox: How to Optimize P2Y12 Inhibitors for Asians?
- LM Bifurcation
- Anticoagulation for TAVR: GALILEO, and Yet It Moves.
- 10-Year Follow-Up of MAIN-COMPARE Registry and Substudies
- OCT Versus IVUS for Guiding PCI: Current Evidences and Ongoing OCTIVUS Trial
- Optimal Antithrombotics After TAVR: Ongoing Trials
- Impact of Severe Coronary Artery Calcification on PCI Outcomes
- Bifurcation PCI: Data, Evidence, and Guidelines
